UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 17, 2020
Accession Number:
0001437749-20-012545
Submission Type:
POS AM
CIK:
0001427925
Company Name:
ACELRX PHARMACEUTICALS INC
File Number:
333-237584